ZYMEWORKS BIOPHARMACEUTICALS 401(K) PLAN
ERISA Form 5500 plan record drawn from DOL EBSA — verify with linked source filings below.
ZYMEWORKS BIOPHARMACEUTICALS INC.
This Profit Sharing plan holds $12M in total assets and serves 124 participants as of 2023. It is sponsored by ZYMEWORKS BIOPHARMACEUTICALS INC. in . The plan reported positive net income of $841K for the year.
What the Filing Says About ZYMEWORKS BIOPHARMACEUTICALS 401(K) PLAN
ZYMEWORKS BIOPHARMACEUTICALS 401(K) PLAN is a Profit Sharing retirement plan sponsored by ZYMEWORKS BIOPHARMACEUTICALS INC., headquartered in . As of the 2023 Form 5500 filing, the plan reports $12M in total end-of-year assets and covers 124 participants across the Manufacturing industry. The sponsor's EIN on file with the U.S. Department of Labor is 472569713, and the plan has been effective since 2015-01-01. Its filing status is currently FILING RECEIVED.
Year over year, total assets moved from $11M at the beginning of 2023 to $12M at year-end — a gain of 7.4%. Net assets (after liabilities) closed the year at $12M, with reported net income of $841K driven by investment returns, contributions received, and benefit payments during the period. These figures reflect what the plan administrator certified on Schedule H or Schedule I of the Form 5500 annual return and can be compared against 2 prior plan-year filings from the same sponsor shown below.
Asset totals and participant counts reflect a single plan year snapshot and can change materially with market conditions, plan mergers, or workforce changes. Fields such as "net income" include both realized investment performance and contribution/distribution flows — a single-year figure does not by itself indicate plan health or participant outcomes. This page summarizes public DOL disclosures for research and educational purposes only and is not retirement, tax, legal, or financial advice. Before making decisions about your own retirement benefits or evaluating an employer's plan, verify the underlying filing directly via the DOL EFAST2 system and consult a qualified professional.
Financial Summary (2023)
| Total Assets (Beginning of Year) | $11M |
| Total Assets (End of Year) | $12M |
| Net Assets (End of Year) | $12M |
| Net Income | $841K |
| Plan Type | Profit Sharing |
| Employer EIN | 472569713 |
| Plan Effective Date | 2015-01-01 |
| Filing Status | FILING RECEIVED |
Sponsor Plan History (ZYMEWORKS BIOPHARMACEUTICALS INC.)
| Year | Plans | Participants | Total Assets |
|---|---|---|---|
| 2022 | 1 | 220 | $11M |
| 2023 | 1 | 124 | $12M |
| 2024 | 1 | 74 | $12M |
Nearby Profit Sharing Plans in
Peer Profit Sharing plans — same state, same plan type — ranked by total assets.
- DAVID OPPENHEIMER AND COMPANY 401(K) PLAN $42M · 178
- POLLARD (U.S.) LTD 401(K) PLAN $35M · 890
- PANELMATIC,INC. EMPLOYEE STOCK OWNERSHIP PLAN $24M · 150
- SEOUL FOREIGN SCHOOL RETIREMENT PLAN $13M · 90
- VENTERRA REALTY INC. 401(K) PLAN $10M · 624
Related Data
Guides
Related Data on Other Portals
Frequently Asked Questions
How much money is in the ZYMEWORKS BIOPHARMACEUTICALS 401(K) PLAN? ▼
What type of plan is ZYMEWORKS BIOPHARMACEUTICALS 401(K) PLAN? ▼
Who sponsors the ZYMEWORKS BIOPHARMACEUTICALS 401(K) PLAN? ▼
How did ZYMEWORKS BIOPHARMACEUTICALS 401(K) PLAN perform in 2023? ▼
Where can I find official filings for ZYMEWORKS BIOPHARMACEUTICALS 401(K) PLAN? ▼
How does ZYMEWORKS BIOPHARMACEUTICALS 401(K) PLAN compare to other plans? ▼
Explore PlainRetire
Source: U.S. Department of Labor, Employee Benefits Security Administration (EBSA), Form 5500 public disclosure dataset. Plan year 2023.
Source: DOL EFAST2 filing system (efast.dol.gov) — original filing retrieval by EIN 472569713.
Reference: IRS Publication 560 — Retirement Plans for Small Business, contribution-limit rules.
Reference: IRS Publication 590-B — Distributions from IRAs, RMD rules under SECURE Act 2.0.
Read our methodology — how this data is sourced, computed, and verified.